These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23361964)

  • 1. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland.
    Hemming M; Räsänen S; Huhti L; Paloniemi M; Salminen M; Vesikari T
    Eur J Pediatr; 2013 Jun; 172(6):739-46. PubMed ID: 23361964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease of Rotavirus Gastroenteritis to a Low Level Without Resurgence for Five Years After Universal RotaTeq Vaccination in Finland.
    Hemming-Harlo M; Markkula J; Huhti L; Salminen M; Vesikari T
    Pediatr Infect Dis J; 2016 Dec; 35(12):1304-1308. PubMed ID: 27455440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland.
    Hemming-Harlo M; Vesikari T; Uhari M; Renko M; Salminen M; Torcel-Pagnon L; Hartwig S; Simondon F; Bricout H
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):317-323. PubMed ID: 27760800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominance of norovirus and sapovirus in Nicaragua after implementation of universal rotavirus vaccination.
    Bucardo F; Reyes Y; Svensson L; Nordgren J
    PLoS One; 2014; 9(5):e98201. PubMed ID: 24849288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).
    Hemming-Harlo M; Gylling A; Herse F; Haavisto I; Nuutinen M; Pasternack M; Kanibir MN; Hartwig S; Carias C
    Vaccine; 2022 Jun; 40(29):3942-3947. PubMed ID: 35641360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®.
    Hartwig S; Uhari M; Renko M; Bertet P; Hemming M; Vesikari T
    BMC Health Serv Res; 2014 Dec; 14():632. PubMed ID: 25494641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute gastroenteritis hospitalizations after implementation of universal mass vaccination against rotavirus.
    Kõivumägi K; Toompere K; Soeorg H; Kallas E; Jõgeda EL; Huik K; ; Lutsar I
    Vaccine; 2020 Mar; 38(13):2879-2886. PubMed ID: 32067818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections.
    Zlamy M; Kofler S; Orth D; Würzner R; Heinz-Erian P; Streng A; Prelog M
    BMC Infect Dis; 2013 Mar; 13():112. PubMed ID: 23452879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel.
    Muhsen K; Kassem E; Rubenstein U; Goren S; Ephros M; Cohen D; Shulman LM
    Vaccine; 2016 Nov; 34(48):5916-5922. PubMed ID: 27771186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009-2010.
    Puustinen L; Blazevic V; Salminen M; Hämäläinen M; Räsänen S; Vesikari T
    Scand J Infect Dis; 2011 Oct; 43(10):804-8. PubMed ID: 21696253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.
    Räsänen S; Lappalainen S; Halkosalo A; Salminen M; Vesikari T
    Scand J Infect Dis; 2011 Jan; 43(1):58-63. PubMed ID: 20807022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city, Japan.
    Yoshikawa T; Matsuki T; Sato K; Mizuno M; Shibata M; Hasegawa S; Morita M; Iwasa M; Gopala K; Holl K
    Vaccine; 2018 Jan; 36(4):527-534. PubMed ID: 29248263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis.
    Muhsen K; Haklai Z; Applbaum Y; Gordon ES; Shteiman A; Glatman-Freedman A; Leshem E
    Vaccine; 2020 Feb; 38(10):2406-2415. PubMed ID: 32029322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is rotavirus still a major cause for diarrheal illness in hospitalized pediatric patients after rotavirus vaccine introduction in the Saudi national immunization program?
    Hegazi MA; Sayed MH; Sindi HH; Bekhit OE; El-Deek BS; Alshoudri FMY; Noorelahi AK
    Medicine (Baltimore); 2017 Apr; 96(15):e6574. PubMed ID: 28403085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence of an increase in the incidence of norovirus gastroenteritis hospitalizations in young children after the introduction of universal rotavirus immunization in Israel.
    Muhsen K; Kassem E; Rubenstein U; Goren S; Ephros M; Shulman LM; Cohen D
    Hum Vaccin Immunother; 2019; 15(6):1284-1293. PubMed ID: 30945960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of rotavirus vaccine on admissions due to acute gastroenteritis and rotavirus gastroenteritis in Israel.
    Klivitsky A; Algabria S; Paret G; Michaan N; Goldberg L; Halutz O; Grisaru-Soen G
    Acta Paediatr; 2021 Feb; 110(2):634-640. PubMed ID: 32654273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcare.
    Leino T; Baum U; Scott P; Ollgren J; Salo H
    Vaccine; 2017 Oct; 35(42):5611-5617. PubMed ID: 28893475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis.
    Tafalla M; Gardovska D; Gopala K; Kozlovska L
    Hum Vaccin Immunother; 2019; 15(6):1272-1278. PubMed ID: 30335570
    [No Abstract]   [Full Text] [Related]  

  • 20. Rotavirus gastroenteritis hospitalization rates and correlation with rotavirus vaccination coverage in Sicily.
    Restivo V; Caracci F; Sannasardo CE; Scarpitta F; Vella C; Ventura G; Tramuto F; Costantino C
    Acta Biomed; 2018 Oct; 89(3):437-442. PubMed ID: 30333453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.